Eden Research (LON:EDEN) Trading Down 3.3% – Here’s Why

Eden Research plc (LON:EDEN)’s share price dropped 3.3% during trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a 50 day simple moving average of GBX 3.87 and a 200 day simple moving average of GBX 3.95. The firm has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insiders Place Their Bets

In other news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,958.74). Also, insider Alexander John Abrey purchased 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.